- Home
- NKGN vs KZR Comparison
NKGN vs KZR Comparison
Compare NKGN & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKGN
- KZR
- Stock Information
- Founded
- NKGN 2017
- KZR 2015
- Country
- NKGN United States
- KZR United States
- Employees
- NKGN N/A
- KZR N/A
- Industry
- NKGN Biotechnology: Biological Products (No Diagnostic Substances)
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- NKGN Health Care
- KZR Health Care
- Exchange
- NKGN Nasdaq
- KZR Nasdaq
- Market Cap
- NKGN 37.8M
- KZR 43.0M
- IPO Year
- NKGN N/A
- KZR 2018
- Fundamental
- Price
- NKGN $0.57
- KZR $6.05
- Analyst Decision
- NKGN
- KZR Hold
- Analyst Count
- NKGN 0
- KZR 2
- Target Price
- NKGN N/A
- KZR $9.00
- AVG Volume (30 Days)
- NKGN 10.4M
- KZR 26.2K
- Earning Date
- NKGN 04-15-2025
- KZR 03-13-2025
- Dividend Yield
- NKGN N/A
- KZR N/A
- EPS Growth
- NKGN N/A
- KZR N/A
- EPS
- NKGN N/A
- KZR N/A
- Revenue
- NKGN N/A
- KZR N/A
- Revenue This Year
- NKGN N/A
- KZR N/A
- Revenue Next Year
- NKGN N/A
- KZR N/A
- P/E Ratio
- NKGN N/A
- KZR N/A
- Revenue Growth
- NKGN N/A
- KZR N/A
- 52 Week Low
- NKGN $0.20
- KZR $5.20
- 52 Week High
- NKGN $4.06
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- NKGN 52.48
- KZR 43.79
- Support Level
- NKGN $0.40
- KZR $5.86
- Resistance Level
- NKGN $0.91
- KZR $6.57
- Average True Range (ATR)
- NKGN 0.13
- KZR 0.27
- MACD
- NKGN 0.00
- KZR 0.02
- Stochastic Oscillator
- NKGN 40.78
- KZR 25.97
About NKGN NKGen Biotech Inc.
NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.